focus -WSS

focus

author：leisure time 2025-10-02 00:27:35 - browse：86716

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Female surgeons have lower rates of long

entertainment

hotspot

WSS

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Cloning humans is technically possible. It's curious no one has tried

Medicare to cover more brain scans related to Alzheimer’s drugs

STAT Readout: Today's biotech news includes Sana and Amylyx

Death of patient in Alzheimer’s trial raises question of possible risks

Medicare to cover more brain scans related to Alzheimer’s drugs

hotspot

focus

entertainment

Virginia high school admissions case could be legal follow

STAT Readout Newsletter: Today in biotech, life science news

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The story of mRNA: From a loose idea to a tool that may help curb Covid

Bright Health sells Medicare Advantage business to Molina

Wellcome Trust names Røttingen as its new CEO

Supreme Court strikes down use of affirmative action

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Wildfire smoke exposes gaps in outdoor worker protections

Nick Jonas talks about managing diabetes along with his career

hotspot

European regulators recommend Amylyx's ALS drug be rejected

With FDA staff opposed to Sarepta therapy, top official intervened

Ask STAT: What do you want to know about ChatGPT in medicine?

New guidelines on severe brain injury complicate already difficult decisions

The strategy behind pharma's lawsuits over drug pricing reform

Peter Marks talks Operation Warp Speed for Rare Diseases

entertainment

explore

hotspot

leisure time